| Revenue | NOK 287,8M | +18% |
| EBITDA | NOK 18,6M | +63% |
| Net profit | NOK 15,4M | +51% |
| Total assets | NOK 110,4M | +17% |
| Equity | NOK 32,4M | +91% |
| Employees | 55 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 245 113 | 229 946 | 225 438 | 243 073 | 287 761 |
| Staff expenses | −59 197 | −57 637 | −0 | −0 | −61 819 |
| EBITDA | 14 069 | 9 761 | 8 811 | 11 367 | 18 579 |
| Depreciation & amort. | −1 025 | −1 085 | −1 056 | −936 | −1 135 |
| EBIT | 13 044 | 8 676 | 7 755 | 10 431 | 17 444 |
| Net financials | 203 | −116 | 2 034 | 2 810 | 2 406 |
| Profit before tax | 13 247 | 8 560 | 9 789 | 13 240 | 19 850 |
| Tax | 2 984 | 1 960 | 2 258 | 3 009 | 4 443 |
| Net profit | 10 263 | 6 600 | 7 531 | 10 232 | 15 406 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 98 589 | 68 745 | 84 370 | 94 188 | 110 374 |
| Equity | 25 625 | 15 641 | 14 599 | 17 007 | 32 413 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 72 964 | 53 104 | 69 771 | 77 181 | 77 961 |
| Total debt | 72 964 | 53 104 | 69 771 | 77 181 | 77 961 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MO Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2008 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 | |
Drger Medical International Gmbh | Company | 100% | 100% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Marie Opdahl | Chief Executive Officer | 0 companies |
| Hans Martin Ingebrigtsen | Chief Executive Officer | 0 companies |
| Thomas Engler | Chairman | 0 companies |